Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.
作者信息
Splinter T A, ten Kate F J, Schröder F H, Denis L, Newling D, Jones W G, Jacqmin D, Boeken Kruger C G, Stoter G, de Voogt H J
机构信息
University Hospital Dijkzigt, Rotterdam.
出版信息
Prog Clin Biol Res. 1988;269:579-90.
PMID:3393555
Abstract
摘要
相似文献
1
2
Preoperative chemotherapy in T3-T4 Nx Mo bladder cancer with cisplatinum and methotrexate.顺铂和甲氨蝶呤用于T3-T4 Nx Mo期膀胱癌的术前化疗。
Prog Clin Biol Res. 1988;260:571-7.
3
[Neoadjuvant chemotherapy using cisplatin (CDDP) and methotrexate (MTX) in carcinoma of the bladder].[顺铂（CDDP）和甲氨蝶呤（MTX）用于膀胱癌的新辅助化疗]
Arch Ital Urol Nefrol Androl. 1990 Jun;62(2):249-55.
4
Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
Prog Clin Biol Res. 1988;260:551-5.
5
6
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
Semin Urol. 1990 Aug;8(3):190-6.
7
8
Chemotherapy for advanced urothelial cancer.晚期尿路上皮癌的化疗
Semin Urol. 1983 Feb;1(1):60-74.
9
10
Pre surgery chemotherapy in bladder cancer.
Prog Clin Biol Res. 1988;260:585-9.
Zotero 插件